Not all individuals with CLL call for therapy. Even with all modern improvements, the iwCLL nevertheless suggests watchful observation for individuals with asymptomatic illness.86 This advice is predicated on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F